OBEFAZIMOD IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: EFFICACY AND SAFETY ANALYSIS FROM THE 96-WEEK OPEN-LABEL MAINTENANCE PHASE 2B STUDY

Severine Vermeire  ¹     Josianne Nitcheu  ²     Paul GINESTE     Sheldon Sloan     Hartmut Ehrlich     Bruce E. Sands  ^3    
1 University Hospitals Leuven, Leuven, Belgium
² Abivax, Paris, France
³ Icahn School of Medicine at Mount Sinai, New York, United States

Topic
Endoscopy, Histopathology, IBD

Session
The new kids on the block for IBD: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)